Skip to main content

Advertisement

ADVERTISEMENT

News

Myriad Morcells – Aroa Biosurgery

https://wcsecure.weblink.com.au/pdf/ARX/02830769.pdf

Aroa reported they are expanding the MASTRR study to 15 sites and 800 patients (previous target of 10 sites and 300 patients) and will leverage data from the 300 enrollments completed to date to publish study results based on sub-group analysis of procedures.Q125 ASX Earnings Release

Advertisement

Advertisement

Advertisement